Author:
Ashby Damien,Choi Peter,Bloom Stephen
Reference151 articles.
1. Ansell D, Feehally J, Fogarty D, Tomson C, Williams AJ, Warwick G. The Renal Association UK Renal Registry. The 11th Annual Report. Bristol, UK; 2008.
2. Ansell D, Roderick P, Hodsman A, Ford D, Steenkamp R, Tomson C. Survival and causes of death of UK adult patients on renal replacement therapy in 2007: National and centre-specific analyses. Nephron Clin Pract. 2009;111(Suppl 1c):c113–39.
3. Wanner C, Krane V, Marz W, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353:238–48.
4. Iseki K, Yamazato M, Tozawa M, Takishita S. Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int. 2002;61:1887–93.
5. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int. 1999;55:1560–7.